Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04856163 · ClinicalTrials.gov registry record · NA
The Impact of Telelactation Services on Breastfeeding Outcomes
A NA study of Breastfeeding, sponsored by RAND.
- Completed
- Registry status
- NA
- Development phase
- 2,108
- Enrollment target
- 1
- Study location
NCT04856163: Completed NA study of Breastfeeding, sponsored by RAND.
NCT04856163 is a NA study of Breastfeeding that has completed, run by RAND. The registered enrollment target is 2,108 participants, above the 539-participant average among 36 other Breastfeeding trials with a reported enrollment target (291% higher). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT04856163, a NA study of Breastfeeding, has completed, sponsored by RAND.
- COMPLETED
- Registry status
- NA
- Development phase
- 2,108 participants
- Enrollment target
- 1
- Study location
Study Summary
This project will assess the impact of a novel breastfeeding support intervention ("telelactation"), delivered via video calls on personal devices including mobile phones and tablets. The goal of this intervention is to increase access to International Board Certified Lactation Consultants to improve, and reduce disparities in, breastfeeding rates. By implementing a digital randomized controlled trial that recruits participants through a popular pregnancy tracker mobile phone application, this mixed methods study will recruit a national sample of 1800-2400 individuals (depending on rate of attrition) during their third trimester of pregnancy to 1) provide evidence on the effectiveness of a widely available, yet understudied, service and 2) leverage technology to promote one of the most widely recommended health behaviors to improve children's health and to reduce disparities in key maternal and child health outcomes.
Primary Outcome
Number of participants who report any breastfeeding at 6 months
Conditions Studied
Interventions
- BEHAVIORAL Telelactation support
Study Locations (1)
Virginia
- RAND Corporation - Arlington
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 2,108 participants |
| Start Date | 2021-07-08 |
| Est. Completion | 2023-12-31 |
| Phase | NA |
What the finished NCT04856163 record still lists
NCT04856163 is an interventional study that assigns participants to a tested intervention. Its 2,108 participants enrollment target places it among the larger protocols in the corpus, above the 539-participant average among 36 other Breastfeeding trials with a reported enrollment target (291% higher).
The record links to 1 condition, with Breastfeeding appearing as the primary indexed condition, and to 1 intervention - of which Telelactation support is the first listed.
NCT04856163 reports a single indexed study location in Virginia.
Frequently Asked Questions
What is clinical trial NCT04856163 about?
NCT04856163 is a clinical study titled "The Impact of Telelactation Services on Breastfeeding Outcomes". This project will assess the impact of a novel breastfeeding support intervention ("telelactation"), delivered via video calls on personal devices including mobile phones and tablets. The goal of this intervention is to increase access to International Board Certified Lactation Consultants to improv...
What is the current status of trial NCT04856163?
This trial is currently completed. It is a NA study. The enrollment target is 2,108 participants. The study started on 2021-07-08. Estimated completion is 2023-12-31.
What conditions does trial NCT04856163 study?
This clinical trial studies the following conditions: Breastfeeding.
What interventions are being tested in trial NCT04856163?
The interventions under investigation include: Telelactation support (BEHAVIORAL).
Who is sponsoring clinical trial NCT04856163?
This trial is sponsored by RAND, which has 78 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT04856163 being conducted?
This trial has 1 study location across Virginia. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Breastfeeding
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT04856163's enrollment target sits among peer trials
2,108 4th of 36 higher than 33 of 36 other Breastfeeding trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Breastfeeding trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Early Life Exposures Among Children With Sickle Cell Disease
RECRUITING · NA
-
Furthering Equity Through Infant Feeding EDucation and Support
RECRUITING · NA
-
Support Via Online Social Networks to Promote Safe Infant Care Practices
RECRUITING · NA
-
Postnatal Exercise to Activate Baby's Brown Fat
RECRUITING · NA
-
Effect of Prenatal and Postnatal Intervention Strategies on Breastfeeding Outcomes in Women With Excessive Weight (Ready, Set, Nourish Study)
RECRUITING · NA
-
Development of the Couplet Care Bassinet
RECRUITING · NA
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT05967273 · 2,106 participants · NA
CirrhosisRx CDS System
- NCT04649242 · 2,100 participants · Phase 3
Randomized Study in Children and Adolescents With Migraine: Acute Treatment
- NCT05206331 · 2,100 participants · Phase 4
CEM to Reduce Biopsy Rates for Less Than Highly Suspicious Breast Abnormalities: a Prospective Study
- NCT05270499 · 2,100 participants
Aveir VR Real-World Evidence Post-Approval Study
Similar registry start date
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia
- NCT07125183 · started 2026-12 · Phase 2
Study on Efficacy and Tolerability of Weekly Doxorubicin in Elderly Patients With Advanced or Metastatic Leiomyosarcoma
- NCT07292298 · started 2026-11 · Phase 2
Phase 2 Single-Arm Rectal Cancer Brachytherapy for Patients With Low-Lying Residual Adenocarcinoma After Total Neoadjuvant Therapy to Improve Organ Preservation Rates
- NCT04263285 · started 2026-10 · NA
Treatment of Depression Post-SCI